Y-mAbs to Announce 2022 Financial and Operating Results on March 30, 2023 21 March 2023
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Finding the right balance between salary costs and the ability to attract and retain key talent is crucial... Read more
NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Genève og Erlangen – 2. februar 2023: Unilabs, en førende udbyder af diagnostiske services, og Siemens... Read more
Efter et solidt politisk fokus på life science-området, mener Dansk Erhverv ikke, at foden skal slippes... Read more
Biotekselskabet IO Biotech har fået opløftende foreløbige resultater fra et fase 2-forsøg mod lungekræft. Mens... Read more
Et nyt fagligt netværk for kvindelige topledere og specialister med prominente life science-kapaciteter... Read more
Newly appointed CMO with more than 25 years’ experience in vaccine development Fast Track status granted... Read more
Estimated 28% reduction in annual operating expenses for 2023 compared to previously announced guidance... Read more